Trial intelligence / Profile preview

Sevoflurane concentration and emergence delirium during pediatric MRI

NL-OMON21231Not yet recruiting

Sponsor
Erasmus MC
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of sevoflurane in Emergence agitation (EA) (2 arms), sponsored by Erasmus MC. Primary endpoints: Maximum PAED score within 1 hour after stopping anesthesia and Emergence delirium incidence. Planned start Sep 2011; status: not yet recruiting.

02

Drugs

sevoflurane
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NL-OMON21231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call